Nobel Prize winner Tu Youyou's team on Monday announced major scientific breakthroughs in treatment of artemisinin resistance.
诺贝尔奖得主屠呦呦的团队17日宣布，在青蒿素抗药性治疗方面取得重大科学性突破。
The World Malaria Report 2018 published by the World Health Organization said that global malaria control progress has stalled.
世卫组织发布的《2018年世界疟疾报告》称，全球疟疾防治进展陷入停滞阶段。
Artemisinin resistance and partner drug resistance has been reported in Greater Mekong subregion.
大湄公河次区域已出现青蒿素抗药性和辅助药物抗药性。
In response to this problem, Tu said that after three years of research, her team found treatment to artemisinin resistance.
针对上述问题，屠呦呦表示，经过三年的研究，其团队已找到青蒿素抗药性的治疗方法。
"Prolonging the period of taking the medicine, or replacing the partner drug, could solve the problem of resistance," Tu said.
屠呦呦称，延长用药时间或更换辅助药物可解决抗药性的问题。
Her team also found that artemisinin has a special effect in treating lupus erythematosus.
屠呦呦团队还发现青蒿素在治疗红斑狼疮方面效果独特。
"It has been seen that artemisinin is effective in treating LE. We are cautiously optimistic about the success of experiments," Tu said.
她表示："青蒿素对治疗红斑狼疮存在有效性趋势，我们对试验成功持谨慎的乐观。"
本文来源：中国日报
责任编辑：
杨卉_NQ4978
